Natural Product (NP) Details
| General Information of the NP (ID: NP8646) | |||||
|---|---|---|---|---|---|
| Name |
Arabinogalactan
|
||||
| Synonyms |
Galactoarabinan; 9036-66-2; (+)-Arabinogalactan; ARABINOGALACTAN; 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol; ANW-42610; FT-0604415
Click to Show/Hide
|
||||
| Species Origin | Senegalia senegal ... | Click to Show/Hide | |||
| Senegalia senegal | |||||
| Disease | Elevated blood glucose [ICD-11: MA18] | Phase 1 | [1] | ||
| Structure |
|
Click to Download Mol2D MOL |
|||
| Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
| Formula |
C20H36O14
|
||||
| PubChem CID | |||||
| Canonical SMILES |
CC1C(C(C(C(O1)CO)O)OC2C(C(C(C(O2)COC3C(C(C(CO3)O)OC)O)O)OC)O)O
|
||||
| InChI |
1S/C20H36O14/c1-7-11(23)18(12(24)9(4-21)32-7)34-20-15(27)17(29-3)13(25)10(33-20)6-31-19-14(26)16(28-2)8(22)5-30-19/h7-27H,4-6H2,1-3H3
|
||||
| InChIKey |
SATHPVQTSSUFFW-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 9036-66-2
|
||||
| Herb ID | |||||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
| Rifaximin alpha | Hepatic fibrosis/cirrhosis | Click to Show/Hide the Molecular Data of This Drug | ||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [2] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| In-vivo Model | Retrospective observational survey study | |||||
| Experimental
Result(s) |
Combination therapy with cyclic rifaximin-Alpha and continuous arabinogalactan combined with lactoferrin are effective in SUDD treatment in terms of symptom resolution, bowel movement normalization, prevention of recurrences with very good patient's compliance. | |||||
